Dietary glycotoxins exacerbate progression of experimental fatty liver disease

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 832-838

  Leung, Christopher ^a,b,c   Herath, Chandana B ^a   Jia, Zhiyuan ^a   Goodwin, Michelle ^a,b   Mak, Kai Yan ^a   Watt, Matthew J ^d   Forbes, Josephine M ^c,e   Angus, Peter W ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Advanced glycation end products; Hepatic stellate cell; Non alcoholic fatty liver disease; Oxidative stress; Steatohepatitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 6; MESSENGER RNA; METHIONINE; METHIONINE CHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DISEASE EXACERBATION; GENE EXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER INJURY; MALE; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STEATOSIS; STELLATE CELL; ADVERSE EFFECTS; ANIMAL; COMPLICATION; DEFICIENCY; DIET; INSULIN RESISTANCE; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SPRAGUE DAWLEY RAT; VITAMIN DEFICIENCY;

ANIMALS; CELL PROLIFERATION; CHOLINE DEFICIENCY; DIET; DISEASE PROGRESSION; GENE EXPRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEPATIC STELLATE CELLS; INSULIN RESISTANCE; LIVER; MALE; METHIONINE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84896398724     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.11.033     Document Type: Article

References (39)

1. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, and M. Contreras et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
2. G.E. Arteel Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH? Hepatology 55 2012 2030 2032
3. T. Henle Protein-bound advanced glycation end products (AGEs) as bioactive amino acid derivatives in foods Amino Acids 29 2005 313 322
4. T. Goldberg, W. Cai, M. Peppa, V. Dardaine, B.S. Baliga, and J. Uribarri et al. Advanced glycoxidation end products in commonly consumed foods J Am Diet Assoc 104 2004 1287 1291
5. A. Bierhaus, P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, and B. Arnold et al. Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 2005 876 886
6. Y. Aso, T. Inukai, K. Tayama, and Y. Takemura Serum concentrations of advanced glycation end products are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes Acta Diabetol 37 2000 87 92
7. T. Miyata, O. Hori, J. Zhang, S.D. Yan, L. Ferran, and Y. Iida et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis J Clin Invest 98 1996 1088 1094
8. R. Patel, S.S. Baker, W. Liu, S. Desai, R. Alkhi, and R. Kozielski et al. Effect of dietary advanced glycation end products on mouse liver PLoS One 7 2012 e35143
9. U. Ekong, S. Zeng, H. Dun, N. Feirt, J. Guo, and N. Ippagunta et al. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice J Gastroenterol Hepatol 21 2006 682 688
10. S. Zeng, N. Feirt, M. Goldstein, J. Guarrera, N. Ippagunta, and U. Ekong et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice Hepatology 39 2004 422 432
11. M. Goodwin, C. Herath, Z. Jia, C. Leung, M.T. Coughlan, and J. Forbes et al. Advanced glycation end products augment experimental hepatic fibrosis J Gastroenterol Hepatol 28 2013 369 376
12. C. Lohwasser, D. Neureiter, Y. Popov, M. Bauer, and D. Schuppan Role of the receptor for advanced glycation end products in hepatic fibrosis World J Gastroenterol 15 2009 5789 5798
13. H. Hyogo, S.I. Yamagishi, K. Iwamoto, K. Arihiro, M. Takeuchi, and T. Sato et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis J Gastroenterol Hepatol 22 2007 1112 1119
14. V. Ratziu, M. Munteanu, F. Charlotte, L. Bonyhay, and T. Poynard Fibrogenic impact of high serum glucose in chronic hepatitis C J Hepatol 39 2003 1049 1055
15. K.C. Sourris, B.E. Harcourt, S.A. Penfold, F.Y. Yap, A.L. Morley, and P.E. Morgan et al. Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy Exp Diab Res 2010 2010 1 9
16. K.C. Sourris, B.E. Harcourt, S.A. Penfold, F.Y.T. Yap, A.L. Morley, and P.E. Morgan et al. Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy AGE 4 2010 11
17. S. Francque, S. Wamutu, S. Chatterjee, E. Van Marck, A. Herman, and A. Ramon et al. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model Liver Int 30 2010 365 375
18. I.A. Leclercq, G.C. Farrell, J. Field, D.R. Bell, F.J. Gonzalez, and G.R. Robertson CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J Clin Invest 105 2000 1067 1075
19. A.L.Y. Tan, K.C. Sourris, B.E. Harcourt, V. Thallas-Bonke, S. Penfold, and S. Andrikopoulos et al. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy Am J Physiol Renal Physiol 298 2010 F763 F770
20. M.T. Coughlan, V. Thallas-Bonke, J. Pete, D.M. Long, A. Gasser, and D.C.K. Tong et al. Combination therapy with the AGE cross-link breaker, alagebrium and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology 148 2007 886 895
21. C. Tikellis, M.C. Thomas, B.E. Harcourt, M.T. Coughlan, J. Pete, and K. Bialkowski et al. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs Am J Physiol Endocrinol Metab 295 2008 E323
22. S. Patella, D.J. Phillips, J. Tchongue, D.M. de Kretser, and W. Sievert Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis Am J Physiol Gastrointest Liver Physiol 290 2006 G137
23. E.L.M. Guimarães, C. Empsen, A. Geerts, and L.A. van Grunsven Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells J Hepatol 52 2010 389 397
24. A. Wieckowska, B.G. Papouchado, Z.Z. Li, R. Lopez, N.N. Zein, and A.E. Feldstein Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am J Gastroenterol 103 2008 1372 1379
25. S. Zeng, Q.Y. Zhang, J. Huang, S. Vedantham, R. Rosario, and R. Ananthakrishnan et al. Opposing roles of RAGE and Myd88 signaling in extensive liver resection FASEB J 26 2012 882 893
26. V. Thallas-Bonke, S.R. Thorpe, M.T. Coughlan, K. Fukami, F.Y.T. Yap, and K.C. Sourris et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway Diabetes 57 2008 460 469
27. G. Poli, F. Biasi, and G. Leonarduzzi 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases Mol Aspects Med 29 2008 67 71
28. M.E. Rinella, and R.M. Green The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance J Hepatol 40 2004 47 51
29. N. Ahmed Advanced glycation end products - role in pathology of diabetic complications Diabetes Res Clin Pract 67 2005 3 21
30. K. Iwamoto, K. Kanno, H. Hyogo, S.-I. Yamagishi, M. Takeuchi, and S. Tazuma et al. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells J Gastroenterol 43 2008 298 304
31. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products Circulation 114 2006 597 605
32. M. Kugelmas, D.B. Hill, B. Vivian, L. Marsano, and C.J. McClain Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E Hepatology 38 2003 413 419
33. H.L. Reeves, and S.L. Friedman Activation of hepatic stellate cells-a key issue in liver fibrosis Front Biosci 7 2002 808 826
34. K. Iwamoto, K. Kanno, H. Hyogo, S. Yamagishi, M. Takeuchi, and S. Tazuma et al. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells J Gastroenterol 43 2008 298 304
35. H. Hyogo, and S. Yamagishi Advanced glycation end products (AGEs) and their involvement in liver disease Curr Pharm Des 14 2008 969 972
36. R. Zamora, and F.J. Hidalgo Coordinate contribution of lipid oxidation and Maillard reaction to the nonenzymatic food browning Crit Rev Food Sci Nutr 45 2005 49 59
37. J. Uribarri, W. Cai, M. Peppa, S. Goodman, L. Ferrucci, and G. Striker et al. Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging J Gerontol A Biol Sci Med Sci 62 2007 427 433
38. J. Uribarri, S. Woodruff, S. Goodman, W. Cai, X. Chen, and R. Pyzik et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet J Am Diet Assoc 110 2010 e912
39. L. Cordain, S.B. Eaton, A. Sebastian, N. Mann, S. Lindeberg, and B.A. Watkins et al. Origins and evolution of the Western diet: health implications for the 21st century Am J Clin Nutr 81 2005 341 354